查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595271

Peri -植体炎市场：按类型、最终用户划分 - 全球预测 2025-2030

Peri-implantitis Market by Type (Non-Surgical, Surgical), End-User (Dental Clinics, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，週边-植体炎市值为9.5671亿美元，预计2024年将达到10.5004亿美元，复合年增长率为9.84%，到2030年将达到18.4654亿美元。

植体周围植入是一种影响人工植牙周围组织的发炎疾病，由于老化和口腔健康意识增强导致植入手术数量不断增加，对牙科领域构成了重大挑战。它的定义是发炎导致骨质流失，威胁植入的稳定性。植体周围植入可能会影响人工植牙的使用寿命，因此解决植体周围炎需要强而有力的预防、诊断和治疗应用。这些应用包括抗菌治疗、机械清创和再生技术。最终用户范围从牙科诊所到医院再到研究机构，凸显了医疗保健环境中需求的多样性。市场成长受到牙科技术进步、患者对美容牙科解决方案的偏好增加以及研发方面的大量投资等因素的影响。特别是，在开发创新治疗方法和再生解决方案以及利用遗传和微生物知识的个人化医疗方法方面正在出现商机。牙科相关人员也在寻求先进的诊断工具以进行早期检测，这为市场扩张提供了一个不断增长的利基市场。然而，市场限制包括治疗成本高、保险覆盖范围不足以及缺乏标准化治疗通讯协定，这些都阻碍了广泛采用。其他挑战包括准确诊断植体周围植入和有效治疗晚期病例的复杂性。创新对于反应灵敏的植入的生医材料开发、增强抗菌表面的奈米技术以及用于预测诊断的机器学习等领域至关重要。市场的性质仍然非常活跃，将牙科、生物技术和材料科学结合在一起的跨学科合作潜力巨大。公司需要透过专注于策略伙伴关係、对从业人员的继续教育以及对研发的大量投资来保持领先地位。透过成功地探索这些维度，我们相信我们将能够提高市场渗透率并在植体周围植入的治疗解决方案方面处于主导。

主要市场统计
基准年[2023] 95671万美元
预测年份 [2024] 1,050,040,000 美元
预测年份 [2030] 18.4654亿美元
复合年增长率（%） 9.84%

市场动态：快速发展的植入市场的关键市场洞察

供需的动态交互作用正在改变植体周围植入市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 植入周围炎盛行率增加
    • 吸烟和糖尿病人口迅速增加
    • 由于植入的增加导致老年人口增加
  • 市场限制因素
    • 缺乏手术相关知识与费用
  • 市场机会
    • 雷射去污等技术创新与进步
  • 市场挑战
    • 临床限制和功能挑战

波特五力：驾驭植入周围炎市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解植体周围植入市场的外部影响

外部宏观环境因素在影响植体周围植入市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解植体周围植入市场的竞争状况

对植入周围炎市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位植入植体周围炎市场供应商的绩效评估

FPNV 定位矩阵是评估植入市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和植入绘製植体周围炎市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，植入周围炎市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 植入周围炎盛行率增加
      • 易患吸烟和糖尿病的人口迅速增加
      • 老年人口增加和人工植牙增加
    • 抑制因素
      • 缺乏手术知识和费用
    • 机会
      • 雷射去污等技术创新与进步
    • 任务
      • 临床限制和功能挑战
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章植入市场：依类型

  • 非手术的
    • 抗生素
    • 雷射清创术
    • 机械清创术
  • 外科手术
    • 骨再生
    • 植入术
    • 开瓣清创术

第七章植入周围炎市场：依最终使用者分类

  • 牙医诊所
  • 医院

第八章北美和南美植入周围炎市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区植入周围炎市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲植入周围炎市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • Aetna Inc.
  • Basic Pharma Life Science Pvt Ltd.
  • botiss biomaterials GmbH
  • Dawood & Tanner by Dentex Manco Limited
  • Geistlich Pharma AG
  • Healthy Life Pharma Pvt. Ltd.
  • Jiangsu Yenssen Biotech Co., Ltd.
  • Neoss Limited
  • Pfizer Inc.
  • Prachi Pharmaceuticals Private Limited.
  • Silveraid Srl
  • Small Lab Co., Ltd.
  • Straumann Group
  • vVARDIS AG
Product Code: MRR-4103B31E019B

The Peri-implantitis Market was valued at USD 956.71 million in 2023, expected to reach USD 1,050.04 million in 2024, and is projected to grow at a CAGR of 9.84%, to USD 1,846.54 million by 2030.

Peri-implantitis, an inflammatory condition affecting the tissues around dental implants, poses significant challenges in the field of dentistry, driven by increasing implant procedures due to aging populations and rising awareness of oral health. Its definition covers inflammation leading to bone loss, endangering implant stability. The necessity for addressing peri-implantitis lies in its potential to compromise the longevity of dental implants, necessitating robust prevention, diagnostic, and treatment applications. These applications encompass antimicrobial therapies, mechanical debridement, and regenerative techniques. End-users span dental clinics, hospitals, and research institutions, highlighting the diversified demand across healthcare settings. Market growth is influenced by factors like advancing dental technologies, increasing patient inclination towards aesthetic dental solutions, and substantial investments in R&D. Opportunities emerge particularly in developing innovative treatment modalities and regenerative solutions, along with personalized medicine approaches utilizing genetic and microbiomic insights. Dental professionals also push for advanced diagnostic tools for early detection, which presents a growing niche for market expansion. However, market limitations include high treatment costs, inadequate insurance coverage, and a lack of standardized treatment protocols, which hamper widespread adoption. Other challenging factors involve the complexity of diagnosing peri-implantitis accurately and effectively treating advanced cases. Innovation is crucial in areas like biomaterial development for more responsive implants, nanotechnology for enhanced antimicrobial surfaces, and machine learning for predictive diagnostics. The market's nature remains highly dynamic, with significant potential in interdisciplinary collaborations bringing together dentistry, biotechnology, and materials science. Firms should focus on strategic partnerships, continuous education for practitioners, and investing heavily in R&D to stay ahead. Successfully navigating these dimensions could lead to significant market penetration and leadership in peri-implantitis treatment solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 956.71 million
Estimated Year [2024] USD 1,050.04 million
Forecast Year [2030] USD 1,846.54 million
CAGR (%) 9.84%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Peri-implantitis Market

The Peri-implantitis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of peri-implantitis
    • Burgeoning population prone to smoking and diabetes
    • Rise in elderly populace coupled with increasing dental implants
  • Market Restraints
    • Lack of knowledge and cost linked with surgery
  • Market Opportunities
    • Technological innovation and advancements such as laser decontamination
  • Market Challenges
    • Clinical limitations and functional challenges

Porter's Five Forces: A Strategic Tool for Navigating the Peri-implantitis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Peri-implantitis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Peri-implantitis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Peri-implantitis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Peri-implantitis Market

A detailed market share analysis in the Peri-implantitis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Peri-implantitis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Peri-implantitis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Peri-implantitis Market

A strategic analysis of the Peri-implantitis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Peri-implantitis Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Aetna Inc., Basic Pharma Life Science Pvt Ltd., botiss biomaterials GmbH, Dawood & Tanner by Dentex Manco Limited, Geistlich Pharma AG, Healthy Life Pharma Pvt. Ltd., Jiangsu Yenssen Biotech Co., Ltd., Neoss Limited, Pfizer Inc., Prachi Pharmaceuticals Private Limited., Silveraid S.r.l., Small Lab Co., Ltd., Straumann Group, and vVARDIS AG.

Market Segmentation & Coverage

This research report categorizes the Peri-implantitis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Non-Surgical and Surgical. The Non-Surgical is further studied across Antibiotics, Laser Debridement, and Mechanical Debridement. The Surgical is further studied across Bone Regeneration, Implanto-Plasty, and Open Flap Debridement.
  • Based on End-User, market is studied across Dental Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of peri-implantitis
      • 5.1.1.2. Burgeoning population prone to smoking and diabetes
      • 5.1.1.3. Rise in elderly populace coupled with increasing dental implants
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of knowledge and cost linked with surgery
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovation and advancements such as laser decontamination
    • 5.1.4. Challenges
      • 5.1.4.1. Clinical limitations and functional challenges
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Peri-implantitis Market, by Type

  • 6.1. Introduction
  • 6.2. Non-Surgical
    • 6.2.1. Antibiotics
    • 6.2.2. Laser Debridement
    • 6.2.3. Mechanical Debridement
  • 6.3. Surgical
    • 6.3.1. Bone Regeneration
    • 6.3.2. Implanto-Plasty
    • 6.3.3. Open Flap Debridement

7. Peri-implantitis Market, by End-User

  • 7.1. Introduction
  • 7.2. Dental Clinics
  • 7.3. Hospitals

8. Americas Peri-implantitis Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Peri-implantitis Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Peri-implantitis Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Aetna Inc.
  • 3. Basic Pharma Life Science Pvt Ltd.
  • 4. botiss biomaterials GmbH
  • 5. Dawood & Tanner by Dentex Manco Limited
  • 6. Geistlich Pharma AG
  • 7. Healthy Life Pharma Pvt. Ltd.
  • 8. Jiangsu Yenssen Biotech Co., Ltd.
  • 9. Neoss Limited
  • 10. Pfizer Inc.
  • 11. Prachi Pharmaceuticals Private Limited.
  • 12. Silveraid S.r.l.
  • 13. Small Lab Co., Ltd.
  • 14. Straumann Group
  • 15. vVARDIS AG

LIST OF FIGURES

  • FIGURE 1. PERI-IMPLANTITIS MARKET RESEARCH PROCESS
  • FIGURE 2. PERI-IMPLANTITIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PERI-IMPLANTITIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PERI-IMPLANTITIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PERI-IMPLANTITIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PERI-IMPLANTITIS MARKET DYNAMICS
  • TABLE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY LASER DEBRIDEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MECHANICAL DEBRIDEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANTO-PLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY OPEN FLAP DEBRIDEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. PERI-IMPLANTITIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. PERI-IMPLANTITIS MARKET, FPNV POSITIONING MATRIX, 2023